Showing results (241-250 of 262) with videos related to

Sort By:
Pageof 27
Atherosclerosis|October 8, 2020
Estimation of the major cardiovascular events prevention with InclisiranAlberto Cordero, Carlos G Santos-Gallego, Lorenzo Fácila, et al.
Journal of Clinical Lipidology|September 29, 2023
The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular eventsAlberto Cordero, Rosa Fernández Olmo, Lina Badimon, et al.
Nature Cardiovascular Research|August 28, 2024
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failureChristiane E Angermann, Carlos G Santos-Gallego, Juan Antonio Requena-Ibanez, et al.
Journal of the American College of Cardiology|April 20, 2019
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial EnergeticsCarlos G Santos-Gallego, Juan Antonio Requena-Ibanez, Rodolfo San Antonio, et al.
Current Cardiology Reports|January 3, 2026
Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging TherapiesUsman Alam, Sheetal V Mathai, Annalisa Filtz, et al.
Journal of the American College of Cardiology|November 3, 2001
Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic controlJ I Osende, J J Badimon, V Fuster, et al.
Circulation. Cardiovascular Interventions|August 4, 2017
Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With TicagrelorM Urooj Zafar, Donald A Smith, Usman Baber, et al.
European Heart Journal|October 28, 2008
Diesel exhaust inhalation increases thrombus formation in manAndrew J Lucking, Magnus Lundback, Nicholas L Mills, et al.
Pageof 27